Breast cancer remodels lymphatics in sentinel lymph nodes

Dominik Eichin, Diana Lehotina, Anni Kauko, Maki Uenaka, Meri Leppänen, Kati Elima, Minna Piipponen, Tapio Lönnberg, Pia Boström, Ilkka Koskivuo, Tero Aittokallio, Maija Hollmén, Akira Takeda, Sirpa Jalkanen

Research output: Contribution to journalArticleScientificpeer-review

Abstract

Cancer metastasis to sentinel lymph nodes (LNs) is often the first marker of potential disease progression. Although it is recognized that tumor-induced lymphangiogenesis facilitates metastasis into LNs in murine models, tumor-induced alterations in human lymphatic vessels remain obscure. Here we use single-cell RNA sequencing and high-resolution spatial transcriptomics to profile lymphatic endothelial cell (LEC) subsets in paired metastatic and non-metastatic LNs obtained from female patients with treatment-naïve breast cancer. Tumor metastasis decreases immunoregulatory LEC subsets, such as PD-L1+ subcapsular sinus LECs, while inducing an increase in capillary-like CD200+ HEY1+ LECs. Matrix Gla protein (MGP) is the most upregulated gene in metastatic LN LECs, and its expression on LECs is TGF-β and VEGF dependent. Upregulated MGP promotes cancer cell adhesion to LN lymphatics. Thus, breast cancer cell metastasis to LNs remodels LEC subsets in human LNs and escalates MGP expression, potentially facilitating cancer cell dissemination through the lymphatic system.

Original languageEnglish
Article number10056
JournalNature Communications
Volume16
Issue number1
Number of pages20
ISSN2041-1723
DOIs
Publication statusPublished - 17 Nov 2025
MoE publication typeA1 Journal article-refereed

Bibliographical note

Publisher Copyright:
© The Author(s) 2025.

Fields of Science

  • 3111 Biomedicine

Cite this